Solve Therapeutics, Inc.

Biotechnology ResearchCalifornia, United States11-50 Employees

Solve Therapeutics, Inc. is a biotechnology research company based in San Diego, California. It is developing antibody-drug conjugates that are engineered for selective targeting and optimized delivery of their payloads. The company frames its approach around optimizing the three components of an ADC—the antibody, the linker, and the payload—so they work together to improve the treatment's benefit-risk profile for patients. This strategy aims to address well-known ADC challenges such as off-target toxicity and suboptimal payload delivery.

In addition, Solve is pursuing patient-selection diagnostics to help identify individuals most likely to benefit from its therapies. Its platform combines antibody engineering with a hydrophilic and highly stable linker system known as CloakLink and an integrated diagnostic capability. With a modest-sized team, the San Diego company positions itself at the intersection of therapeutics and diagnostics, focusing on treatments where selection of suitable patients can influence outcomes.

Sign up for free to view info

Email Format Employee directory